^
BIOMARKER:
CDK12 mutation
i
Other names: CDK12, Cyclin Dependent Kinase 12, Cdc2-Related Kinase, Arginine/Serine-Rich, Cell Division Cycle 2-Related Protein Kinase 7, Cell Division Protein Kinase 12, CDC2-Related Protein Kinase 7, Cyclin-Dependent Kinase 12, CRKRS, CRK7, CDC2 Related Protein Kinase 7, HCDK12, CrkRS, CRKR
Entrez ID:
Related biomarkers:
CDK12 mutation
Prostate Cancer
olaparib
Sensitive
:
A2
CDK12 mutation
Prostate Cancer
nivolumab
Sensitive
:
C2
CDK12 mutation
HER2 Negative Breast Cancer
durvalumab
Sensitive
:
C2
CDK12 mutation
Prostate Cancer
pembrolizumab
Sensitive
:
C3
CDK12 mutation
Prostate Cancer
abiraterone acetate
Resistant
:
C3
CDK12 mutation
Prostate Cancer
enzalutamide
Resistant
:
C3
CDK12 mutation
Prostate Cancer
rucaparib
Resistant
:
C3
CDK12 mutation
Prostate Cancer
AST-2970
Resistant
:
C3
CDK12 mutation
Breast Cancer
olaparib
Sensitive
:
C3
CDK12 mutation
Prostate Cancer
GnRH stimulant
Resistant
:
C3
CDK12 mutation
Prostate Cancer
Immunotherapy
Resistant
:
C3
CDK12 mutation
Prostate Cancer
enzalutamide + abiraterone acetate
Resistant
:
C3
CDK12 mutation
NSCLC
olaparib
Sensitive
:
C4
CDK12 mutation
Prostate Cancer
nivolumab + ipilimumab
Sensitive
:
C4
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our